RNS Number:4189N
CeNeS Pharmaceuticals PLC
10 July 2003


                            CeNeS Pharmaceuticals Plc
                                        
                                        
              Transfer to the Alternative Investment Market ("AIM")



As previously indicated on 2 July 2003, the Board of CeNeS Pharmaceuticals Plc
("CeNeS" or the "Company") announces that it intends to apply to the UK Listing
Authority ("UKLA") for the cancellation of its listing of the entire issued
ordinary share capital from the Official List of the UKLA ("Official List") and
to apply to the London Stock Exchange for admission to trading on AIM. It is
anticipated that dealings will commence in the Company's shares on AIM on 8
August 2003 and that the Company's listing on the Official List will be
cancelled on the same day.


The Directors of CeNeS believe that it is more appropriate and cost efficient
for the Company's shares to be traded on the AIM market as it is less regulated
than the Official List.


10 July 2003




Enquiries:

CeNeS Pharmaceuticals Plc                                        01223 266 466
Neil Clark
Evolution Beeson Gregory                                         020 7488 4040
Matt Wood







                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCEBLFFXDBLBBK